In this issue:
Wells rule with D-dimer excludes PE in primary care
Age-dependent D-dimer cutoffs for DVT exclusion in primary care
Aspirin for preventing VTE recurrence
Oral rivaroxaban for symptomatic PE
Dabigatran, rivaroxaban or apixaban vs. enoxaparin after hip/knee replacement
Heart rate recovery predicts PAH worsening
Exercise in pulmonary hypertension
Atorvastatin in PAH
Treprostinil with endothelin receptor antagonist and/or
PDE-5 inhibitor for PAH
Targeted BMPR2 delivery attenuates pulmonary hypertension
Please login below to download this issue (PDF)